Leigh Farrell
Director/Board Member at PRO MEDICUS LIMITED
Net worth: 286 991 $ as of 2024-03-30
Profile
Leigh Bernard Farrell is currently an Independent Non-Executive Director at Pro Medicus Ltd.
He is also the Managing Director & Executive Director at Adned Pty Ltd., a Non-Executive Director at Ena Respiratory Pty Ltd., a Member at the Australian Institute of Co. Directors, and the Head-Health Security Division at DMTC Ltd.
In the past, Dr. Farrell has worked as the Chief Executive Officer at Gene Shears Pty Ltd., Chairman & Chief Operating Officer at d3 Medicine LLC, Associate Director at GBS Venture Partners Pty Ltd., Director at Cortical Pty Ltd., Research Manager at Johnson & Johnson Research Pty Ltd., Senior Vice President-Commercial at Certara USA, Inc., and Vice President-Business Development at Aviragen Therapeutics, Inc.Dr. Farrell obtained his undergraduate and doctorate degrees from Monash University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
PRO MEDICUS, LTD.
0.00% | 2023-06-29 | 4,240 ( 0.00% ) | 286 991 $ | 2024-03-30 |
Leigh Farrell active positions
| Companies | Position | Start |
|---|---|---|
| PRO MEDICUS LIMITED | Director/Board Member | 2017-09-07 |
Australian Institute of Co. Directors
 Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Corporate Officer/Principal | - |
| Adned Pty Ltd. | Chief Executive Officer | - |
Ena Respiratory Pty Ltd.
 Ena Respiratory Pty Ltd. BiotechnologyHealth Technology Ena Respiratory Pty Ltd. operates as a biotechnology company. It develops novel, synthetic innate immunomodulators for the prevention of respiratory viral and bacterial infections. The company is headquartered in Melbourne, Australia. | Director/Board Member | - |
| DMTC Ltd. | Corporate Officer/Principal | - |
Former positions of Leigh Farrell
| Companies | Position | End |
|---|---|---|
| Gene Shears Pty Ltd. | Chief Executive Officer | - |
d3 Medicine LLC
 d3 Medicine LLC Pharmaceuticals: MajorHealth Technology d3 Medicine LLC develops drugs and medicines. It is strategic advisory company focused on developing medicines for use in indications including infectious diseases, oncology, and inflammation. The company was founded by Craig Rayner in 2012 and is headquartered in Parsippany, NJ. | Chairman | - |
GBS Venture Partners Pty Ltd.
 GBS Venture Partners Pty Ltd. Investment ManagersFinance GBS Venture Partners Pty Ltd (GBS Venture Partners) is a venture capital firm founded in 1996 by Helen Brigitte Smith and Geoff E.D Brooke. The firm is headquartered in Melbourne. | Corporate Officer/Principal | - |
Aviragen Therapeutics, Inc.
 Aviragen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aviragen Therapeutics, Inc. engages in the discovery and development of direct-acting antivirals to treat infections. Its product candidates include vapendavir, an oral treatment for human rhinovirus infections in moderate-to-severe asthmatics; BTA074, a topical antiviral treatment for genital warts caused by human papillomavirus types 6 & 11; BTA585, an oral fusion protein inhibitor for the treatment of RSV-A and RSV-B infections; and laninamivir octanoate, a one-time, inhaled treatment for influenza A and B infections. The company was founded on November 8, 2012 and is headquartered in Alpharetta, GA. | Corporate Officer/Principal | - |
| ░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Leigh Farrell
| Monash University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PRO MEDICUS LIMITED | Health Services |
| Private companies | 11 |
|---|---|
GBS Venture Partners Pty Ltd.
GBS Venture Partners Pty Ltd. Investment ManagersFinance GBS Venture Partners Pty Ltd (GBS Venture Partners) is a venture capital firm founded in 1996 by Helen Brigitte Smith and Geoff E.D Brooke. The firm is headquartered in Melbourne. | Finance |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Commercial Services |
| Johnson & Johnson Research Pty Ltd. | |
Cortical Pty Ltd.
 Cortical Pty Ltd. BiotechnologyHealth Technology Cortical Pty Ltd. discovers and develops medical drugs for the treatment of inflammatory and proliferative diseases. The company was founded in 2003 by Eric F. Morand and Magdy N. Iskander and is headquartered in Clayton, Australia. | Health Technology |
| Gene Shears Pty Ltd. | |
Certara USA, Inc.
 Certara USA, Inc. Miscellaneous Commercial ServicesCommercial Services Certara USA, Inc. provides drug development consultancy solutions. It offers benefits of modeling and simulation, label optimization, pediatric drug development, orphan drug development, clinical trial outcomes databases, and therapeutic areas. The company was founded in 2008 and is headquartered in Princeton, NJ. | Commercial Services |
Aviragen Therapeutics, Inc.
Aviragen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aviragen Therapeutics, Inc. engages in the discovery and development of direct-acting antivirals to treat infections. Its product candidates include vapendavir, an oral treatment for human rhinovirus infections in moderate-to-severe asthmatics; BTA074, a topical antiviral treatment for genital warts caused by human papillomavirus types 6 & 11; BTA585, an oral fusion protein inhibitor for the treatment of RSV-A and RSV-B infections; and laninamivir octanoate, a one-time, inhaled treatment for influenza A and B infections. The company was founded on November 8, 2012 and is headquartered in Alpharetta, GA. | Health Technology |
| DMTC Ltd. | |
d3 Medicine LLC
d3 Medicine LLC Pharmaceuticals: MajorHealth Technology d3 Medicine LLC develops drugs and medicines. It is strategic advisory company focused on developing medicines for use in indications including infectious diseases, oncology, and inflammation. The company was founded by Craig Rayner in 2012 and is headquartered in Parsippany, NJ. | Health Technology |
| Adned Pty Ltd. | |
Ena Respiratory Pty Ltd.
Ena Respiratory Pty Ltd. BiotechnologyHealth Technology Ena Respiratory Pty Ltd. operates as a biotechnology company. It develops novel, synthetic innate immunomodulators for the prevention of respiratory viral and bacterial infections. The company is headquartered in Melbourne, Australia. | Health Technology |
- Stock Market
- Insiders
- Leigh Farrell
